The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
856
November 1, 1991
View Complete Issue         Table of Contents 2019 
Issue 856
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Monoclonal For Gram-Negative Sepsis
November 1, 1991 (Issue: 856)
HA-1A (Centoxin - Centocor), a monoclonal IgM antibody against endotoxin from gram-negative bacteria, may soon be approved for marketing by the US Food and Drug Administration. Commercially available in Europe, HA-1A has been used in the USA as an...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 856
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.